Literature DB >> 12757039

A prioritised research agenda for DOTS-Plus for multidrug-resistant tuberculosis (MDR-TB).

Rajesh Gupta, Marcos Espinal.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12757039

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN： 1027-3719            Impact factor:   2.373


× No keyword cloud information.
  11 in total

1.  Tuberculosis control: challenges of an ancient and ongoing epidemic.

Authors:  Kristin J Cummings
Journal:  Public Health Rep       Date:  2007 Sep-Oct       Impact factor: 2.792

Review 2.  A balancing act: efflux/influx in mycobacterial drug resistance.

Authors:  G E Louw; R M Warren; N C Gey van Pittius; C R E McEvoy; P D Van Helden; T C Victor
Journal:  Antimicrob Agents Chemother       Date:  2009-05-18       Impact factor: 5.191

Review 3.  Multidrug-resistant to extensively drug resistant tuberculosis: what is next?

Authors:  Amita Jain; Pratima Dixit
Journal:  J Biosci       Date:  2008-11       Impact factor: 1.826

Review 4.  The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells.

Authors:  Véronique Dartois
Journal:  Nat Rev Microbiol       Date:  2014-02-03       Impact factor: 60.633

Review 5.  Priorities for tuberculosis research: a systematic review.

Authors:  Jamie Rylance; Madhukar Pai; Christian Lienhardt; Paul Garner
Journal:  Lancet Infect Dis       Date:  2010-11-01       Impact factor: 25.071

6.  Setting priorities for a research agenda to combat drug-resistant tuberculosis in children.

Authors:  B Velayutham; D Nair; S Ramalingam; C M Perez-Velez; M C Becerra; S Swaminathan
Journal:  Public Health Action       Date:  2015-12-21

7.  In-house, simple & economical phage technique for rapid detection of rifampicin, isoniazid, ethambutol, streptomycin & ciprofloxacin drug resistance using Mycobacterium tuberculosis isolates.

Authors:  Nanda Hemvani; Vikas Patidar; D S Chitnis
Journal:  Indian J Med Res       Date:  2012-05       Impact factor: 2.375

8.  Bridging the gap between policy and practice: a qualitative analysis of providers' field experiences tinkering with directly observed therapy in patients with drug-resistant tuberculosis in Addis Ababa, Ethiopia.

Authors:  Kirubel Manyazewal Mussie; Christoph Gradmann; Tsegahun Manyazewal
Journal:  BMJ Open       Date:  2020-06-16       Impact factor: 2.692

9.  Scaling up programmatic management of drug-resistant tuberculosis: a prioritized research agenda.

Authors:  Frank G J Cobelens; Einar Heldal; Michael E Kimerling; Carole D Mitnick; Laura J Podewils; Rajeswari Ramachandran; Hans L Rieder; Karin Weyer; Matteo Zignol
Journal:  PLoS Med       Date:  2008-07-08       Impact factor: 11.069

Review 10.  Programmatic Management of Drug-Resistant Tuberculosis: An Updated Research Agenda.

Authors:  Carole D Mitnick; Carly A Rodriguez; Marita L Hatton; Grania Brigden; Frank Cobelens; Martin P Grobusch; Robert Horsburgh; Christoph Lange; Christian Lienhardt; Eyal Oren; Laura J Podewils; Barbara Seaworth; Susan van den Hof; Charles L Daley; Agnes C Gebhard; Fraser Wares
Journal:  PLoS One       Date:  2016-05-25       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.